Enhanced Antibody Detection and Diagnosis of Coccidioidomycosis with the MiraVista IgG and IgM Detection Enzyme Immunoassay
Open Access
- 1 March 2017
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 55 (3) , 893-901
Abstract
Coccidioidomycosis is a common cause of community-acquired pneumonia in areas of the southwestern United States in which the disease is endemic. Clinical presentations range from self-limited disease to severe disseminated disease. Therefore, early and accurate diagnosis is essential to ensure appropriate treatment and monitoring. Currently available diagnostic tests have variable accuracy, particularly in certain patient populations, and new tests may offer improved accuracy for the diagnosis of coccidioidomycosis. Serum samples from 103 cases of coccidioidomycosis and 373 controls were tested for IgG and IgM antibodies using the MVista anti- Coccidioides antibody enzyme immunoassay. Serum specimens from 170 controls from areas in which the disease is endemic and 44 cases were tested by immunodiffusion at MiraVista Diagnostics. The sensitivity of the MVista antibody assay was 88.3%, and the specificity was 90%. The sensitivity was maintained in the presence of immunocompromising conditions or immunosuppressive therapies. The sensitivity of immunodiffusion was 60.2%, and the specificity was 98.8%. The sensitivity of complement fixation (62 cases) was 66.1%, but the specificity could not be determined. The MVista anti- Coccidioides antibody enzyme immunoassay offers improved sensitivity, compared with immunodiffusion and complement fixation, is not impaired in immunocompromised patients, and permits highly reproducible semiquantification.Keywords
This publication has 19 references indexed in Scilit:
- Update on the Diagnosis of Pulmonary CoccidioidomycosisAnnals of the American Thoracic Society, 2014
- Development of a Highly Sensitive and Specific Blastomycosis Antibody Enzyme Immunoassay Using Blastomyces dermatitidis Surface Protein BAD-1Clinical and Vaccine Immunology, 2013
- The Utility of Diagnostic Testing for Active Coccidioidomycosis in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2013
- The diagnosis of coccidioidomycosisF1000 Medicine Reports, 2010
- Testing for Coccidioidomycosis among Patients with Community-Acquired PneumoniaEmerging Infectious Diseases, 2008
- Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hostsMycopathologia, 2006
- Coccidioidomycosis as a Common Cause of Community-acquired PneumoniaEmerging Infectious Diseases, 2006
- Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonistsArthritis & Rheumatism, 2004
- Coccidioidomycosis in Human Immunodeficiency Virus–Infected Persons in Arizona, 1994–1997: Incidence, Risk Factors, and PreventionThe Journal of Infectious Diseases, 2000
- PATTERN OF 39,500 SEROLOGIC TESTS IN COCCIDIOIDOMYCOSISJAMA, 1956